Tiverton Asset Management’s Pfizer PFE Stock Holding History

Tiverton Asset Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$5.78M	Buy	169,581 +27,477	+19%	+$999K	0.2%	111
2019 Q2	$5.84M	Buy	142,104 +37,786	+36%	+$1.5M	0.21%	103
2019 Q1	$4.2M	Buy	+104,318	New	+$4.18M	0.18%	111
2018 Q4	–	Sell	-14,229	Closed	-$595K	–	509
2018 Q3	$595K	Buy	+14,229	New	+$548K	0.03%	233
2018 Q2	–	Sell	-50,105	Closed	-$1.69M	–	482
2018 Q1	$1.69M	Sell	50,105 -48,378	-49%	-$1.66M	0.12%	123
2017 Q4	$3.38M	Buy	+98,483	New	+$3.36M	0.21%	104

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Tiverton Asset Management's PFE Position: Q3 2019 in Review

Tiverton Asset Management increased its Pfizer (PFE) stake by 19% in Q3 2019, buying an estimated $999K and bringing the position to 169,581 shares worth $5.78M. The position accounts for 0.2% of the portfolio, ranked #111.

Tiverton Asset Management first reported a position in PFE in Q4 2017 and has held it in 6 quarters since. The position peaked at $5.84M in Q2 2019. 2,323 funds tracked by Wall St. Rank hold PFE as of Q3 2019.

Tiverton Asset Management held 169,581 shares of Pfizer worth $5.78M as of Q3 2019.
Tiverton Asset Management bought 27,477 Pfizer shares in Q3 2019, an estimated $999K.
Pfizer made up 0.2% of Tiverton Asset Management's portfolio in Q3 2019, its #111 holding.
Tiverton Asset Management first reported a position in Pfizer in Q4 2017 and has held it in 6 quarters since.
Tiverton Asset Management's Pfizer position peaked at $5.84M in Q2 2019.
2,323 funds tracked by Wall St. Rank held Pfizer as of Q3 2019.

Based on Tiverton Asset Management's 13F filing for Q3 2019, filed 13 Nov 2019.